# Medicside

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medicside

- Industry: Medical Devices & Equipment
- Headquarters: Changchun, China
- Website: www.mcside.com
- Latest round: Series A (Nov 28, 2022)
- Investors on record: 2

## About

Based in Changchun, China, and founded in 2017, Medicside is a medical company focusing on the research, development, production, sales, and service of in vitro diagnostic product systems, with GMP workshops and several production lines. The founding team has more than ten years of experience in the research and development of IVD products. The wholly owned subsidiary was established in Zhejiang. In 2022, the products have been put on the market.

The company is dedicated to the R&D, production, and sales of medical equipment and matched reagent consumables.  It provides instrument products and reagent products which include CM-5000 Automated Urine Analysis Assembly Line, MA-500 Urine Sediment Analyzer, CA-500 Urine Analyzer, MCM Sheath, MCC Cleaning, Calibrator, etc. It has been providing services for product distributors and end customers in Asia, the Middle East, Europe, Oceania, Africa, etc.

## Funding rounds

- Series A, Nov 28, 2022 — Jilin Zhongke Venture Capital, Changchun Equity Investment Fund Management

## Investors

- Jilin Zhongke Venture Capital (https://capitalatlas.ai/funds/jilin-zhongke-venture-capital) — Series A
- Changchun Equity Investment Fund Management — Series A